Hafslund Nycomed sets up in South Korea:
This article was originally published in Clinica
Executive Summary
Hafslund Nycomed (Norway) has established a South Korean subsidiary, Nycomed Korea. The company plans to launch the non-ionic X-ray contrast medium, Omnipaque, as well as other contrast agents on the South Korean market, according to Pharma Koreana.